PharmaShots | Incisive News in 3 Shots

Subscribe Now

Children

PharmaShots Interview: GSK’s Tom Corbridge Shares Insights on Nucala as At-Home Treatment Option for Children with Severe Eosinophilic Asthma

PharmaShots Interview: GSK’s Tom Corbridge Shares Insights on Nucala as At-Home Treatment Option for Children with Severe Eosinoph...

May 4, 2022

Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose of their COVID-19 Vaccine in Children Aged 5 Through 11 Years

Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose of their COVID-19 Vaccine in Children Aged 5 Through 11 Years

April 27, 2022

Pfizer and BioNTech Seek Approval for Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age

Pfizer and BioNTech Seek Approval for Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age

April 15, 2022

Regeneron and Sanofi’s Dupixent (dupilumab) Receive EC’s Approval for Children with Severe Asthma with Type 2 Inflammation

Regeneron and Sanofi’s Dupixent (dupilumab) Receive EC’s Approval for Children with Severe Asthma with Type 2 Inflammation

April 7, 2022

Zealand Pharma Report Enrollment Completion in P-III Study of Dasiglucagon in Children with Congenital Hyperinsulinism

Zealand Pharma Report Enrollment Completion in P-III Study of Dasiglucagon in Children with Congenital Hyperinsulinism

February 15, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us